(PRQR) - Earnings & Price History

PRQR: - 3.77, $92.80M, -0.03 (-0.79%)

Sector: Healthcare - Industry: Biotechnology

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. The companys clinical stage candidates include QR-010, a RNA-based oligonucleotide that is in Phase Ib clinical trial for the treatment of cystic fibrosis. It also develops QR-110, which is in pre-clinical development stage for the treatment of Lebers congenital amaurosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.Key Statistics

Past PRQR reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-17-0.53
2017-02-16-0.534.254.154.254.154.252.41%2.41%38.05K
2017-02-15-0.534.154.154.154.074.2595.90K
2016-11-14-0.5555.055.154.955.151.98%▲-2.91%-0.99%110.87K
2016-08-17-0.485.15.385.255.15.36-2.42%-2.86%-5.20%9.32K
2016-05-18-0.413.674.224.33.664.31.90%-14.65%-13.03%104.55K
2016-02-17-0.394.654.624.624.64.730.65%0.65%14.94K
2015-11-23-0.269.259.859.859.19.87-6.09%-6.09%87.40K
2015-08-19-0.3415.316.2316.2415.0516.520.06%-5.79%-5.73%33.04K
2015-05-21-0.2619.5519.6919.6318.9420.01-0.30%-0.41%-0.71%36.25K

Login | Register
Monday Oct 15, 2018   EST
Enter a Ticker:

Economic Calendar

Retail Sales 8:30 AM ET Empire State Mfg Survey 8:30 AM ET Business Inventories 10:00 AM ET 4-Week Bill Announcement 11:00 AM ET 8-Week Bill Announcement 11:00 AM ET 3-Month Bill Auction 11:30 AM ET 6-Month Bill Auction 11:30 AM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades